Planet Biotechnology Incorporated
Hayward, CA
- UEI
- KTJKPBE2H5H3
- CAGE
- 3GTX5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 20980 Corsair Blvd, Hayward, CA 94545, USA
- Website
- planetbiotechnology.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract vehicles
No active vehicles.
1 expired vehicle
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Purchase Order HHSD2002014M59976P | CDC Office of Acquisition Services | $150,000 | |
| 500 MG of ATCRY1 cryptochrome protein and 500 MG of gwcryla cryptochrome protein | Defense Advanced Research Projects Agency | $677,637 | |
| Definitive Contract DAMD1703C0103 | Medical Command (Army) | $849,599 |
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Applied Biotechnology Institute Inc. | San Luis Obispo, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Lumen Bioscience, Inc. | Seattle, WA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Oncotrap Inc. | Chapel Hill, NC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Novab, Inc. | Tucker, GA | 621511 Medical Laboratories |
| Trellis Bioscience, Inc. | — | — |
About the company
Planet Biotechnology Incorporated, doing business as Planet Biotechnology, is a for-profit biotechnology company specializing in the development of novel immunotherapeutics and antibody-derived molecules for treating infectious diseases. Registered to receive federal government awards since 2003, the company utilizes plant-based expression systems to produce recombinant proteins, particularly focusing on fusion proteins that combine elements of human antibodies with other immune system components. Planet Biotechnology's primary focus is on engineering and evaluating these fusion proteins for their potential as treatments or preventatives against various pathogens. The company's expertise lies in developing innovative approaches to combat challenging infectious diseases through the manipulation of immune system components.
Through federal grant awards, primarily from the National Institute of Allergy and Infectious Diseases (NIAID), Planet Biotechnology has been engaged in multiple research projects aimed at developing immunotherapeutics for diseases such as gonorrhea, melioidosis, Lyme disease, and other tick-borne illnesses. The company has received grants to engineer and test Factor H-Fc fusion proteins and other antibody-derived molecules designed to enhance complement-mediated killing of pathogens like Neisseria gonorrhoeae, Burkholderia pseudomallei, and Borrelia burgdorferi. Additionally, Planet Biotechnology has worked on improving gene expression techniques under a grant from the National Institute of General Medical Sciences and developing treatments for uropathogenic E. coli with funding from the National Institute of Diabetes and Digestive and Kidney Diseases. As a subcontractor to the University of Massachusetts Medical School, the company has produced monoclonal antibodies and fusion proteins for gonorrhea research, demonstrating its capabilities in plant-based protein production and its collaborative approach to advancing medical treatments. These projects showcase Planet Biotechnology's role in pioneering novel approaches to combat infectious diseases through the development of specialized immunotherapeutic proteins.
SBA capabilities narrative
research and development and
manufacture of antibodies, immunoadhesins vaccines,recombinant proteins and miRNAs for healthcare and other applications
Quick answers
Is Planet Biotechnology Incorporated registered in SAM.gov?
Yes. Planet Biotechnology Incorporated's SAM.gov registration is active through January 5, 2027.
Which contract vehicles does Planet Biotechnology Incorporated hold?
Planet Biotechnology Incorporated holds a place on 1 federal contract vehicle: DARPA Plant Based Proteins Development and Manufacture.
What is Planet Biotechnology Incorporated's most recent federal award?
Planet Biotechnology Incorporated's most recent federal grant award is Bispecific antibody for topical administration to prevent gonorrhea - 1 gonorrhea affects over 80 million individuals… (R43AI186979), from National Institute of Allergy and Infectious Diseases (NIH), on August 1, 2024.
On GovTribe
See Planet Biotechnology Incorporated's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors